Evidence map›Paper›PMID 29571832›Full record

Observational studyOphthalmology2018

Clinical Prediction Performance of Glaucoma Progression Using a 2-Dimensional Continuous-Time Hidden Markov Model with Structural and Functional Measurements.

Youngseok Song, Hiroshi Ishikawa, Mengfei Wu, Yu-Ying Liu, Katie A Lucy, Fabio Lavinsky, Mengling Liu, Gadi Wollstein, Joel S Schuman

Abstract readObservational Study
In one paragraph

Observational study in Ophthalmology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Youngseok SongNew York University Langone Eye Center, New York University School of Medicine, New York, New York.
Hiroshi IshikawaNew York University Langone Eye Center, New York University School of Medicine, New York, New York.
Mengfei WuNew York University Langone Eye Center, New York University School of Medicine, New York, New York; Division of Biostatistics, Department of Population Health and Environmental Medicine, New York University School of Medicine, New York, New York.
Yu-Ying LiuGeorgia College of Computing, Georgia Institute of Technology, Atlanta, Georgia.
Katie A LucyNew York University Langone Eye Center, New York University School of Medicine, New York, New York.
Fabio LavinskyNew York University Langone Eye Center, New York University School of Medicine, New York, New York.
Mengling LiuDivision of Biostatistics, Department of Population Health and Environmental Medicine, New York University School of Medicine, New York, New York.
Gadi WollsteinNew York University Langone Eye Center, New York University School of Medicine, New York, New York. Electronic address: Gadi.Wollstein@nyumc.org.
Joel S SchumanNew York University Langone Eye Center, New York University School of Medicine, New York, New York.
NYU Langone Health · USGeorgia Institute of Technology · USNew York University · US

Funding

Project-005UL1TR001445 · NCATS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BREDELLA, MIRIAM ANTOINETTE, HOCHMAN, JUDITH S · 2015 to 2025
$103.5M
Novel Glaucoma Diagnostics for Structure and Function - Renewal - 1R01EY013178 · NEI · WILLS EYE HEALTH SYSTEM · PI Joel S Schuman · 2000 to 2026
$17.5M
NCATS NIH HHS UL1 TR001445NEI NIH HHS R01 EY013178
6 · The paper itself

Abstract

purposePreviously, we introduced a state-based 2-dimensional continuous-time hidden Markov model (2D CT HMM) to model the pattern of detected glaucoma changes using structural and functional information simultaneously. The purpose of this study was to evaluate the detected glaucoma change prediction performance of the model in a real clinical setting using a retrospective longitudinal dataset.

designLongitudinal, retrospective study.

participantsOne hundred thirty-four eyes from 134 participants diagnosed with glaucoma or as glaucoma suspects (average follow-up, 4.4±1.2 years; average number of visits, 7.1±1.8).

methodsA 2D CT HMM model was trained using OCT (Cirrus HD-OCT; Zeiss, Dublin, CA) average circumpapillary retinal nerve fiber layer (cRNFL) thickness and visual field index (VFI) or mean deviation (MD; Humphrey Field Analyzer; Zeiss). The model was trained using a subset of the data (107 of 134 eyes [80%]) including all visits except for the last visit, which was used to test the prediction performance (training set). Additionally, the remaining 27 eyes were used for secondary performance testing as an independent group (validation set). The 2D CT HMM predicts 1 of 4 possible detected state changes based on 1 input state.

main outcome measuresPrediction accuracy was assessed as the percentage of correct prediction against the patient's actual recorded state. In addition, deviations of the predicted long-term detected change paths from the actual detected change paths were measured.

resultsBaseline mean ± standard deviation age was 61.9±11.4 years, VFI was 90.7±17.4, MD was -3.50±6.04 dB, and cRNFL thickness was 74.9±12.2 μm. The accuracy of detected glaucoma change prediction using the training set was comparable with the validation set (57.0% and 68.0%, respectively). Prediction deviation from the actual detected change path showed stability throughout patient follow-up.

conclusionsThe 2D CT HMM demonstrated promising prediction performance in detecting glaucoma change performance in a simulated clinical setting using an independent cohort. The 2D CT HMM allows information from just 1 visit to predict at least 5 subsequent visits with similar performance.

Indexed as

Visual AcuityDisease ProgressionFemaleFollow-Up StudiesGlaucomaHumansIntraocular PressureMaleMiddle AgedNerve FibersOptic DiskPredictive Value of TestsProspective StudiesRetinal Ganglion CellsRetrospective StudiesTime Factors

Identifiers

PMID29571832
PMCPMC6109428
OpenAlexW2789604249

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.